Vaccination against Streptococcus pneumoniae using truncated derivatives of polyhistidine triad protein D

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Plumptre, Charles D ^a   Ogunniyi, Abiodun D ^a   Paton, James C ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIGEN; ESCHERICHIA COLI ENDOTOXIN; IMMUNOLOGICAL ADJUVANT; PNEUMOCOCCUS VACCINE; POLYHISTIDINE TRIAD PROTEIN A; POLYHISTIDINE TRIAD PROTEIN B; POLYHISTIDINE TRIAD PROTEIN D; POLYHISTIDINE TRIAD PROTEIN D C1; POLYHISTIDINE TRIAD PROTEIN D C2; POLYHISTIDINE TRIAD PROTEIN D C3; POLYHISTIDINE TRIAD PROTEIN D N1; POLYHISTIDINE TRIAD PROTEIN D N2; POLYHISTIDINE TRIAD PROTEIN D N3; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; HISTIDINE; POLYHISTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; INFECTION PREVENTION; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; PROTEIN BINDING; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; STRUCTURE ANALYSIS; VACCINATION; ANIMAL; BINDING SITE; CHEMISTRY; CIRCULAR DICHROISM; IMMUNOLOGY; PNEUMONIA, PNEUMOCOCCAL; PROCEDURES; SEPSIS; STREPTOCOCCUS PNEUMONIAE;

MURINAE; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BINDING SITES; CIRCULAR DICHROISM; HISTIDINE; MICE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84907090254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078916     Document Type: Article

References (34)

1. McCullers JA, Tuomanen EI (2001) Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 6: D877-89.
2. Briles DE, Paton JC, Hollingshead S (2009) Pneumococcal common proteins and other vaccine strategies. In: Levine MM, Kaper JB, Rappuoli R, Liu M, Good MF, New Generation Vaccines. New York, USA: Marcel Dekker. pp. 908-933.
3. Brueggemann AB, Pai R, Crook DW, Beall B (2007) Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 3: e168.
4. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, et al. (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196: 1346-1354.
5. Hava DL, Camilli A (2002) Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45: 1389-1406.
6. Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, et al. (2004) Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun 72: 5582-5596.
7. Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, et al. (2008) Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 205: 117-131.
8. Ogunniyi AD, Mahdi LK, Trappetti C, Verhoeven N, Mermans D, et al. (2012) Identification of genes that contribute to pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis. Infect Immun 80: 3268-3278.
9. Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC (2007) Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun 75: 350-357.
10. Plumptre CD, Ogunniyi AD, Paton JC (2012) Polyhistidine triad proteins of pathogenic streptococci. Trends Microbiol 20: 485-493.
11. Adamou JE, Heinrichs JH, Erwin AL, Walsh W, Gayle T, et al. (2001) Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun 69: 949-958.
12. Rioux S, Neyt C, Di Paolo E, Turpin L, Charland N, et al. (2010) Transcriptional regulation, occurrence and putative role of the Pht Family of Streptococcus pneumoniae. Microbiology 157: 336-348.
13. Zhang Y, Masi AW, Barniak V, Mountzouros K, Hostetter MK, et al. (2001) Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infect Immun 69: 3827-3836.
14. Hamel J, Charland N, Pineau I, Ouellet C, Rioux S, et al. (2004) Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins. Infect Immun 72: 2659-2670.
15. Beghetto E, Gargano N, Ricci S, Garufi G, Peppoloni S, et al. (2006) Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library. FEMS Microbiol Lett 262: 14-21.
16. Godfroid F, Hermand P, Verlant V, Denoël P, Poolman JT (2011) Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun 79: 238-245.
17. Denoël P, Philipp MT, Doyle L, Martin D, Carletti G, et al. (2011) A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae. Vaccine 29: 5495-5501.
18. Bologa M, Kamtchoua T, Hopfer R, Sheng X, Hicks B, et al. (2012) Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine. Vaccine 30: 7461-7468.
19. Seiberling M, Bologa M, Brookes R, Ochs M, Go K, et al. (2012) Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults. Vaccine 30: 7455-7460.
20. Loisel E, Chimalapati S, Bougault C, Imberty A, Gallet B, et al. (2011) Biochemical characterization of the histidine triad protein PhtD as a cell surface zinc-binding protein of pneumococcus. Biochemistry 50: 3551-3558.
21. Plumptre CD, Ogunniyi AD, Paton JC (2013) Surface association of Pht proteins of Streptococcus pneumoniae. Infect Immun. In press.
22. Cognet I, De Coignac AB, Magistrelli G, Jeannin P, Aubry JP, et al. (2003) Expression of recombinant proteins in a lipid A mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation. J Immunol Methods 272: 199-210.
23. LeMessurier KS, Ogunniyi AD, Paton JC (2006) Differential expression of key pneumococcal virulence genes in vivo. Microbiology 152: 305-311.
24. Lupas A, Van Dyke M, Stock J (1991) Predicting coiled coils from protein sequences. Science 252: 1162-1164.
25. Compton LA, Johnson WC (1986) Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication. Anal Biochem 155: 155-167.
26. Whitmore L, Wallace BA (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32: W668-73.
27. Whitmore L, Wallace BA (2008) Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 89: 392-400.
28. McDaniel LS, Ralph BA, McDaniel DO, Briles DE (1994) Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb Pathog 17: 323-337.
29. Briles DE, Hollingshead SK (2006) Surface proteins of Streptococcus pneumoniae: their roles in virulence and potential as vaccines. Program and abstracts of the 2006 Euroconference on Infections and Lung Diseases. Paris, France.
30. Malley R, Anderson PW (2012) Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc Natl Acad Sci USA 109: 3623-3627.
31. Ogunniyi AD, Folland RL, Briles DE, Hollingshead SK, Paton JC (2000) Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect Immun 68: 3028-3033.
32. Kadioglu A, Andrew PW (2005) Susceptibility and resistance to pneumococcal disease in mice. Brief Funct Genomic Proteomic 4: 241-247.
33. Khan MN, Pichichero ME (2013) CD4 T cell memory and antibody responses directed against pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice. Infect Immun. In press.
34. Paton JC, Lock RA, Lee CJ, Li JP, Berry AM, et al. (1991) Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun 59: 2297-2304.